MH
The startup develops uterine devices specifically designed to manage postpartum hemorrhage through mechanical compression and physiological support. Their technology provides immediate and effective control of blood loss without causing biological or chemical side effects.
Updated 3 months ago
Funding
$860K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops uterine devices specifically designed to manage postpartum hemorrhage through mechanical compression and physiological support. Their technology provides immediate and effective control of blood loss without causing biological or chemical side effects.